SLC30A7
Basic information
Region (hg38): 1:100896076-100996260
Links
Phenotypes
GenCC
Source:
- Joubert syndrome (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Ziegler-Huang syndrome | AR | Allergy/Immunology/Infectious; Endocrine; Hematologic | The condition can include hormone deficiencies, and awareness may allow medical management; Due to mineral abnormalities, supplementation has been described as necessary; The condition may involve bone marrow failure, including neutropenia and thrombocytopenia, and the need for interventions such as RBC transfusions has been described | Allergy/Immunology/Infectious; Endocrine; Hematologic | 36821639 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (48 variants)
- not_provided (19 variants)
- Ziegler-Huang_syndrome (3 variants)
- Decreased_testicular_size (1 variants)
- Severe_early-onset_pulmonary_alveolar_proteinosis_due_to_MARS_deficiency (1 variants)
- Testicular_atrophy (1 variants)
- Joubert_syndrome_1 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC30A7 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000133496.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | |||||
| missense | 50 | 54 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 1 | 2 | 50 | 6 | 2 |
Highest pathogenic variant AF is 0.000011628797
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SLC30A7 | protein_coding | protein_coding | ENST00000370112 | 11 | 85678 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 4.40e-7 | 0.841 | 125712 | 0 | 36 | 125748 | 0.000143 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.467 | 182 | 201 | 0.907 | 0.00000921 | 2485 |
| Missense in Polyphen | 72 | 83.253 | 0.86483 | 1068 | ||
| Synonymous | -0.435 | 79 | 74.2 | 1.06 | 0.00000393 | 718 |
| Loss of Function | 1.49 | 13 | 20.2 | 0.643 | 8.56e-7 | 248 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000303 | 0.000303 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.0000462 | 0.0000462 |
| European (Non-Finnish) | 0.000212 | 0.000202 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.000101 | 0.0000980 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Seems to facilitate zinc transport from the cytoplasm into the Golgi apparatus. Partly regulates cellular zinc homeostasis. Required with ZNT5 for the activation of zinc- requiring enzymes, alkaline phosphatases (ALPs). Transports zinc into the lumens of the Golgi apparatus and the vesicular compartments where ALPs locate, thus, converting apoALPs to holoALPs. Required with ZNT5 and ZNT6 for the activation of TNAP (By similarity). {ECO:0000250, ECO:0000269|PubMed:15276077, ECO:0000269|PubMed:15994300}.;
- Pathway
- Zinc homeostasis;Peptide hormone metabolism;Metabolism of proteins;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Transport of small molecules;Insulin processing;Metal ion SLC transporters;Zinc efflux and compartmentalization by the SLC30 family;Zinc transporters
(Consensus)
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- loftool
- 0.740
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 14.97
Haploinsufficiency Scores
- pHI
- 0.319
- hipred
- Y
- hipred_score
- 0.544
- ghis
- 0.649
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.786
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc30a7
- Phenotype
- growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); digestive/alimentary phenotype;
Gene ontology
- Biological process
- zinc ion transport;sequestering of zinc ion;cation transmembrane transport
- Cellular component
- cytoplasm;Golgi apparatus;integral component of membrane;cytoplasmic vesicle;vesicle;perinuclear region of cytoplasm
- Molecular function
- cation transmembrane transporter activity